Greater activation of peripheral T follicular helper cells following high dose influenza vaccine in older adults forecasts seroconversion

Vaccine

Volumn 35, Issue 2, 2017, Pages 329-336

  Pilkinton, Mark A ^a   Nicholas, Katherine J ^b   Warren, Christian M ^a   Smith, Rita M ^a   Yoder, Sandra M ^a   Talbot, H Keipp ^a   Kalams, Spyros A ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

High dose influenza vaccine; Influenza vaccine; T follicular helper cells; Tfh; viSNE

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CXCR5; INFLUENZA VACCINE;

AGED; ANTIBODY RESPONSE; ARTICLE; CD4+ T LYMPHOCYTE; COMMUNITY CARE; CONTROLLED STUDY; DRUG MEGADOSE; FORECASTING; HEMAGGLUTINATION INHIBITION; HUMAN; INFLUENZA A; INFLUENZA B; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; PHENOTYPE; PLASMABLAST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROCONVERSION; T LYMPHOCYTE ACTIVATION; FEMALE; HELPER CELL; IMMUNOLOGY; MALE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INFLUENZA VACCINES; MALE; SEROCONVERSION; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 85006978091     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2016.11.059     Document Type: Article

References (43)

1. [1] Fulton, R.B., Varga, S.M., Effects of aging on the adaptive immune response to respiratory virus infections. Aging Health, 5, 2009, 775.
2. [2] Goodwin, K., Viboud, C., Simonsen, L., Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 24 (2006), 1159–1169.
3. [3] Thompson, W.W., Shay, D.K., Weintraub, E., Brammer, L., Cox, N., Anderson, L.J., et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA J Am Med Assoc 289 (2003), 179–186.
4. [4] Couch, R.B., Winokur, P., Brady, R., Belshe, R., Chen, W.H., Cate, T.R., et al. Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects. Vaccine 25 (2007), 7656–7663.
5. [5] DiazGranados, C.A., Dunning, A.J., Jordanov, E., Landolfi, V., Denis, M., Talbot, H.K., High-dose trivalent influenza vaccine compared to standard dose vaccine in elderly adults: safety, immunogenicity and relative efficacy during the 2009–2010 season. Vaccine 31 (2013), 861–866.
6. [6] Falsey, A.R., Treanor, J.J., Tornieporth, N., Capellan, J., Gorse, G.J., Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older. J Infect Dis 200 (2009), 172–180.
7. [7] Fiore, A.E., Uyeki, T.M., Broder, K., Finelli, L., Euler, G.L., Singleton, J.A., et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR recommendations and reports: morbidity and mortality weekly report recommendations and reports/centers for disease control 59 (2010), 1–62.
8. [8] Keitel, W.A., Atmar, R.L., Cate, T.R., Petersen, N.J., Greenberg, S.B., Ruben, F., et al. Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons. Arch Intern Med 166 (2006), 1121–1127.
9. [9] DiazGranados, C.A., Dunning, A.J., Kimmel, M., Kirby, D., Treanor, J., Collins, A., et al. Efficacy of high-dose versus standard-dose influenza vaccine in older adults. N Engl J Med 371 (2014), 635–645.
10. [10] DiazGranados, C.A., Robertson, C.A., Talbot, H.K., Landolfi, V., Dunning, A.J., Greenberg, D.P., Prevention of serious events in adults 65 years of age or older: a comparison between high-dose and standard-dose inactivated influenza vaccines. Vaccine 33 (2015), 4988–4993.
11. [11] Izurieta, H.S., Thadani, N., Shay, D.K., Lu, Y., Maurer, A., Foppa, I.M., et al. Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis. Lancet Infect Dis 15 (2015), 293–300.
12. [12] Burns, E.A., Lum, L.G., L'Hommedieu, G., Goodwin, J.S., Specific humoral immunity in the elderly: in vivo and in vitro response to vaccination. J Gerontol 48 (1993), B231–B236.
13. [13] Sasaki, S., Sullivan, M., Narvaez, C.F., Holmes, T.H., Furman, D., Zheng, N.Y., et al. Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies. J Clin Investig 121 (2011), 3109–3119.
14. [14] Linterman, M.A., How T follicular helper cells and the germinal centre response change with age. Immunol Cell Biol 92 (2014), 72–79.
15. [15] Kolar, G.R., Mehta, D., Wilson, P.C., Capra, J.D., Diversity of the Ig repertoire is maintained with age in spite of reduced germinal centre cells in human tonsil lymphoid tissue. Scand J Immunol 64 (2006), 314–324.
16. [16] Eaton, S.M., Burns, E.M., Kusser, K., Randall, T.D., Haynes, L., Age-related defects in CD4 T cell cognate helper function lead to reductions in humoral responses. J Exp Med 200 (2004), 1613–1622.
17. [17] Crotty, S., Follicular helper CD4 T cells (TFH). Annu Rev Immunol 29 (2011), 621–663.
18. [18] Breitfeld, D., Ohl, L., Kremmer, E., Ellwart, J., Sallusto, F., Lipp, M., et al. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J Exp Med 192 (2000), 1545–1552.
19. [19] Rasheed, A.U., Rahn, H.P., Sallusto, F., Lipp, M., Muller, G., Follicular B helper T cell activity is confined to CXCR5(hi)ICOS(hi) CD4 T cells and is independent of CD57 expression. Eur J Immunol 36 (2006), 1892–1903.
20. [20] Chevalier, N., Jarrossay, D., Ho, E., Avery, D.T., Ma, C.S., Yu, D., et al. CXCR5 expressing human central memory CD4 T cells and their relevance for humoral immune responses. J Immunol 186 (2011), 5556–5568.
21. [21] Morita, R., Schmitt, N., Bentebibel, S.E., Ranganathan, R., Bourdery, L., Zurawski, G., et al. Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity 34 (2011), 108–121.
22. [22] Locci, M., Havenar-Daughton, C., Landais, E., Wu, J., Kroenke, M.A., Arlehamn, C.L., et al. Human circulating PD-(+)1CXCR3(-)CXCR5(+) memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses. Immunity 39 (2013), 758–769.
23. [23] Schultz, B.T., Teigler, J.E., Pissani, F., Oster, A.F., Kranias, G., Alter, G., et al. Circulating HIV-specific interleukin-21(+)CD4(+) T cells represent peripheral Tfh cells with antigen-dependent helper functions. Immunity 44 (2016), 167–178.
24. [24] Havenar-Daughton, C., Lindqvist, M., Heit, A., Wu, J.E., Reiss, S.M., Kendric, K., et al. CXCL13 is a plasma biomarker of germinal center activity. Proc Natl Acad Sci USA 113 (2016), 2702–2707.
25. [25] Bentebibel, S.E., Lopez, S., Obermoser, G., Schmitt, N., Mueller, C., Harrod, C., et al. Induction of ICOS+CXCR3+CXCR5+ TH cells correlates with antibody responses to influenza vaccination. Sci Transl Med, 5, 2013, 176ra32.
26. [26] Pallikkuth, S., Parmigiani, A., Silva, S.Y., George, V.K., Fischl, M., Pahwa, R., et al. Impaired peripheral blood T-follicular helper cell function in HIV-infected nonresponders to the 2009 H1N1/09 vaccine. Blood 120 (2012), 985–993.
27. [27] Herati, R.S., Reuter, M.A., Dolfi, D.V., Mansfield, K.D., Aung, H., Badwan, O.Z., et al. Circulating CXCR5+PD-1+ response predicts influenza vaccine antibody responses in young adults but not elderly adults. J Immunol 193 (2014), 3528–3537.
28. [28] Lefebvre, J.S., Masters, A.R., Hopkins, J.W., Haynes, L., Age-related impairment of humoral response to influenza is associated with changes in antigen specific T follicular helper cell responses. Sci Rep, 6, 2016, 25051.
29. [29] Baumjohann, D., Preite, S., Reboldi, A., Ronchi, F., Ansel, K.M., Lanzavecchia, A., et al. Persistent antigen and germinal center B cells sustain T follicular helper cell responses and phenotype. Immunity 38 (2013), 596–605.
30. [30] Boscardin, S.B., Hafalla, J.C., Masilamani, R.F., Kamphorst, A.O., Zebroski, H.A., Rai, U., et al. Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses. J Exp Med 203 (2006), 599–606.
31. [31] Kotecha, N., Krutzik, P.O., Irish, J.M., Web-based analysis and publication of flow cytometry experiments. Curr Protoc Cytom, 2010 [chapter 10:Unit10 7].
32. [32] George, V.K., Pallikkuth, S., Parmigiani, A., Alcaide, M., Fischl, M., Arheart, K.L., et al. HIV infection worsens age-associated defects in antibody responses to influenza vaccine. J Infect Dis 211 (2015), 1959–1968.
33. [33] He, J., Tsai, L.M., Leong, Y.A., Hu, X., Ma, C.S., Chevalier, N., et al. Circulating precursor CCR7(lo)PD-1(hi) CXCR5(+) CD4(+) T cells indicate Tfh cell activity and promote antibody responses upon antigen reexposure. Immunity 39 (2013), 770–781.
34. [34] Fink, K., Origin and function of circulating plasmablasts during acute viral infections. Front Immunol, 3, 2012, 78.
35. [35] Wong, M.T., Chen, J., Narayanan, S., Lin, W., Anicete, R., Kiaang, H.T., et al. Mapping the diversity of follicular helper T cells in human blood and tonsils using high-dimensional mass cytometry analysis. Cell Rep 11 (2015), 1822–1833.
36. [36] Amir el, A.D., Davis, K.L., Tadmor, M.D., Simonds, E.F., Levine, J.H., Bendall, S.C., et al. ViSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia. Nat Biotechnol 31 (2013), 545–552.
37. [37] Li, X., Miao, H., Henn, A., Topham, D.J., Wu, H., Zand, M.S., et al. Ki-67 expression reveals strong, transient influenza specific CD4 T cell responses after adult vaccination. Vaccine 30 (2012), 4581–4584.
38. [38] Li Causi, E., Parikh, S.C., Chudley, L., Layfield, D.M., Ottensmeier, C.H., Stevenson, F.K., et al. Vaccination expands antigen-specific CD4+ memory T cells and mobilizes bystander central memory T cells. PLoS ONE, 10, 2015, e0136717.
39. [39] Boswell, K.L., Paris, R., Boritz, E., Ambrozak, D., Yamamoto, T., Darko, S., et al. Loss of circulating CD4 T cells with B cell helper function during chronic HIV infection. PLoS Pathog, 10, 2014, e1003853.
40. [40] Chen, W.H., Cross, A.S., Edelman, R., Sztein, M.B., Blackwelder, W.C., Pasetti, M.F., Antibody and Th1-type cell-mediated immune responses in elderly and young adults immunized with the standard or a high dose influenza vaccine. Vaccine 29 (2011), 2865–2873.
41. [41] Channappanavar, R., Twardy, B.S., Krishna, P., Suvas, S., Advancing age leads to predominance of inhibitory receptor expressing CD4 T cells. Mech Ageing Dev 130 (2009), 709–712.
42. [42] Weng, N.P., Akbar, A.N., Goronzy, J., CD28(-) T cells: their role in the age-associated decline of immune function. Trends Immunol 30 (2009), 306–312.
43. [43] Tubo, N.J., Pagan, A.J., Taylor, J.J., Nelson, R.W., Linehan, J.L., Ertelt, J.M., et al. Single naive CD4+ T cells from a diverse repertoire produce different effector cell types during infection. Cell 153 (2013), 785–796.